ARS Pharmaceuticals' Neffy, an epinephrine nasal spray, is poised as a game-changer for emergency allergies, driving growth.

Shares of Evoke Pharma are trading sharply higher Wednesday morning. The specialty pharma company received a U.S. Patent ...

Snot plays a powerful role in protecting us from disease – and its colour alone can provide insights into what's going on in ...

Vitamin B12 supplements might be recommended to people who are at particular risk of being deficient in it. This includes ...

Johnson & Johnson shows steady growth in Q2, driven by medtech and oncology, yet talc litigation overshadows. Click for my ...

Atai Life Sciences (NASDAQ:ATAI) is one of the best-performing NASDAQ stocks according to analysts. On July 1, Atai Life ...

Calling upon all relevant stakeholders to position local pharmaceutical manufacturing as a ‘thrust industry’ which can reduce ...

The Salvation Army urges public access to emergency drug-reversal kits as fatalities soar and awareness remains dangerously ...

Jessica Tarlov’s voice is more than just unique; it’s kind, courageous and desperately needed. Trump's attacks are indecent and brutish ...

Esketamine, a form of ketamine taken as a nasal spray, has been approved for the treatment for moderate to severe treatment-resistant depression in Scotland but intravenous ketamine has not, though it ...

For parents of kids with severe food allergies like mine, the rite of passage that is starting primary school is fraught with very real, very deadly fears that they will come to serious harm – or ...